Korean J Radiol.  2009 Feb;10(1):34-42. 10.3348/kjr.2009.10.1.34.

Percutaneous Radiofrequency Ablation for the Hepatocellular Carcinoma Abutting the Diaphragm: Assessment of Safety and Therapeutic Efficacy

• Kang TW
• Rhim H
• Kim EY
• Kim YS
• Choi D
• Lee WJ
• Lim HK

• KMID: 1088676
• DOI: http://doi.org/10.3348/kjr.2009.10.1.34

Abstract

OBJECTIVE
To assess the safety and therapeutic efficacy of a percutaneous radiofrequency (RF) ablation for the hepatocellular carcinoma (HCC) abutting the diaphragm. MATERIALS AND METHODS: We retrospectively assessed 80 patients who underwent a percutaneous RF ablation for a single nodular (< 4 cm) HCC over the last four years. Each patient underwent an ultrasound-guided RF ablation using internally cooled electrodes for the first-line treatment. We divided patients into two subgroups based on whether the index tumor was abutting (less than 5 mm) the diaphragm or not: group A (abutting; n = 31) versus group B (non-abutting; n = 49). We compared the two subgroups for complications and therapeutic efficacy using image and the review of medical records. The statistical assessment included an independent t-test, Fisher's exact test, and chi-square test. RESULTS: The assessment of the diaphragmatic swelling at CT immediately following the procedure was more severe in group A than group B (mean thickness change:1.44 vs. 0.46 mm, p = 0.00). Further, right shoulder pain was more common in group A than B (p = 0.01). Although minor complications (hemothorax 1 case, pleural effusion 1 case) were noted only in group A, no major thoracic complication occurred in either group. The technical success rate was lower in group A than group B (84% vs. 98%, p = 0.03). As well, the primary and secondary technique effectiveness rates in group A and group B were 90% versus 98% (p = 0.29) and 79% versus 91% (p = 0.25), respectively. The local tumor progression rate was higher in group A than in group B (29% vs. 6%, p = 0.02). CONCLUSION: We found that the percutaneous RF ablation for the HCC abutting the diaphragm is a safe procedure without major complications. However, it is less effective with regard to technical success and local tumor control.

Keyword

Hepatocellular carcinoma; Diaphragm; Radiofrequency ablation; Ultrasonography; Computed tomography (CT)

MeSH Terms

Adult
Aged
Aged, 80 and over
Burns/etiology
Carcinoma, Hepatocellular/pathology/*surgery
Catheter Ablation/*adverse effects
Diaphragm/injuries/pathology
Female
Humans
Liver Neoplasms/pathology/*surgery
Lung Injury/etiology
Male
Middle Aged
Shoulder Pain/etiology
Treatment Outcome
Young Adult

Figure

• 

  Fig. 1 Comparison of diaphragm thickness between abutting group A and non-abutting group B. Graph shows changes in diaphragmatic thickness in two groups after radiofrequency ablation. Mean increase in diaphragmatic thickness between pre- and immediately after radiofrequency ablation on CT scanning was 1.44 mm for abutting group A and 0.46 mm for non-abutting group B. This difference was statistically significant (p < 0.01). Diaphragmatic thickness spontaneously decreased over time.

• 

  Fig. 2 76-year-old man with hepatocellular carcinoma showing diaphragm swelling and enhancement. A. Portal phase CT scan obtained prior to radiofrequency ablation shows enhancing nodule (black arrow) in segment VIII. White line = diameter of diaphragm thickness. B. Portal phase CT scan obtained immediately after radiofrequency ablation shows ablation zone (A) with minimal amount of fluid collection. Swelling and enhancement of diaphragm is noted as thermal injury for abutting ablation zone (white arrow). White line = diameter of diaphragm thickness.

• 

  Fig. 3 67-year-old man with hepatocellular carcinoma showing incomplete ablation and hemothorax. A. Arterial phase CT scan obtained immediately after first session of radiofrequency ablation shows residual enhancing lesion (white arrow) at central portion of index tumor. B. Second radiofrequency ablation session of residual tumor was performed on next day. However, persistent enhancing viable portion at ablation margin is noted immediately after radiofrequency ablation (white arrow). Hemothorax (H) at right lung is associated with diaphragmatic thermal injury. At that time, patient's vital signs were stable and resulted in use of conservative treatments only.

• 

  Fig. 4 69-year-old man with hepatocellular carcinoma showing transient lung injury. A. Arterial phase CT scan obtained prior to radiofrequency ablation shows enhancing nodule abutting diaphragm in liver segment VII (black arrow). B. In lung window setting obtained immediately after radiofrequency ablation indicated abnormal parenchymal density at right lower lobe (white arrow). Patient was asymptomatic at time. C. Without any specific treatment, lesion resolved at one month follow-up CT scan.

• 

  Fig. 5 Flow diagram showing primary and secondary technique effectiveness rates in this study. At one month follow-up CT, primary technique effectiveness rates was 90% (28/31) in group A, compared to 98% (48/49) in group B (p = 0.29). Among 80 patients, secondary technique effectiveness rates was evaluated in 59 patients who had one year or more of follow-up with CT. Secondary technique effectiveness rates was 79% (19/24) in group A, compared to 91% (32/35) in group B (p = 0.25). Both primary and secondary technique effectiveness rates showed no statistically measurable difference. Group A = abutting diaphragm, group B = non-abutting diaphragm

Reference

1. Iannitti DA, Dupuy DE, Mayo-Smith WW, Murphy B. Hepatic radiofrequency ablation. Arch Surg. 2002. 137:422–426.

2. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, et al. Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions. Radiology. 2000. 214:761–768.

3. Chen MH, Yang W, Yan K, Gao W, Dai Y, Wang YB, et al. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol. 2005. 11:6395–6401.

4. de Baere T, Risse O, Kuoch V, Dromain C, Sengel C, Smayra T, et al. Adverse events during radiofrequency treatment of 582 hepatic tumors. AJR Am J Roentgenol. 2003. 181:695–700.

5. Rhim H, Dodd GD 3rd, Chintapalli KN, Wood BJ, Dupuy DE, Hvizda JL, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics. 2004. 24:41–52.

6. Rhim H, Yoon KH, Lee JM, Cho Y, Cho JS, Kim SH, et al. Major complications after radio-frequency thermal ablation of hepatic tumors: spectrum of imaging findings. Radiographics. 2003. 23:123–134.

7. Choi D, Lim HK, Kim MJ, Kim SH, Lee WJ, Kim SH, et al. Therapeutic efficacy and safety of percutaneous radiofrequency ablation of hepatocellular carcinoma abutting the gastrointestinal tract. AJR Am J Roentgenol. 2004. 183:1417–1424.

8. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003. 226:441–451.

9. Ohmoto K, Tsuduki M, Shibata N, Takesue M, Kunieda T, Yamamoto S. Percutaneous microwave coagulation therapy for hepatocellular carcinoma located on the surface of the liver. AJR Am J Roentgenol. 1999. 173:1231–1233.

10. Ohmoto K, Yamamoto S. Percutaneous microwave coagulation therapy for superficial hepatocellular carcinoma on the liver surface. Am J Gastroenterol. 2000. 95:2401–2403.

11. Hori T, Nagata K, Hasuike S, Onaga M, Motoda M, Moriuchi A, et al. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation. J Gastroenterol. 2003. 38:977–981.

12. Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003. 97:1253–1262.

13. Kim YJ, Raman SS, Yu NC, Busuttil RW, Tong M, Lu DS. Radiofrequency ablation of hepatocellular carcinoma: can subcapsular tumors be safely ablated? AJR Am J Roentgenol. 2008. 190:1029–1034.

14. Koda M, Ueki M, Maeda N, Murawaki Y. Diaphragmatic perforation and hernia after hepatic radiofrequency ablation. AJR Am J Roentgenol. 2003. 180:1561–1562.

15. Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience. AJR Am J Roentgenol. 2008. 190:91–98.

16. Teratani T, Yoshida H, Shiina S, Obi S, Sato S, Tateishi R, et al. Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations. Hepatology. 2006. 43:1101–1108.

17. Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 3rd, Dupuy DE, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology. 2005. 235:728–739.

18. Bolser DC, Hobbs SF, Chandler MJ, Ammons WS, Brennan TJ, Foreman RD. Convergence of phrenic and cardiopulmonary spinal afferent information on cervical and thoracic spinothalamic tract neurons in the monkey: implications for referred pain from the diaphragm and heart. J Neurophysiol. 1991. 65:1042–1054.

19. Demling RH. The burn edema process: current concepts. J Burn Care Rehabil. 2005. 26:207–227.

20. Lund T, Onarheim H, Reed RK. Pathogenesis of edema formation in burn injuries. World J Surg. 1992. 16:2–9.

21. Head HW, Dodd GD 3rd, Dalrymple NC, Prasad SR, El-Merhi FM, Freckleton MW, et al. Percutaneous radiofrequency ablation of hepatic tumors against the diaphragm: frequency of diaphragmatic injury. Radiology. 2007. 243:877–884.

22. Cho YK, Rhim H, Ahn YS, Kim MY, Lim HK. Percutaneous radiofrequency ablation therapy of hepatocellular carcinoma using multitined expandable electrodes: comparison of subcapsular and nonsubcapsular tumors. AJR Am J Roentgenol. 2006. 186:S269–S274.

23. Sartori S, Tombesi P, Macario F, Nielsen I, Tassinari D, Catellani M, et al. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness. Radiology. 2008. 248:670–679.

24. Kapoor BS, Hunter DW. Injection of subphrenic saline during radiofrequency ablation to minimize diaphragmatic injury. Cardiovasc Intervent Radiol. 2003. 26:302–304.

25. Kim YS, Rhim H, Paik SS. Radiofrequency ablation of the liver in a rabbit model: creation of artificial ascites to minimize collateral thermal injury to the diaphragm and stomach. J Vasc Interv Radiol. 2006. 17:541–547.

26. Minami Y, Kudo M, Kawasaki T, Chung H, Ogawa C, Shiozaki H. Percutaneous radiofrequency ablation guided by contrast-enhanced harmonic sonography with artificial pleural effusion for hepatocellular carcinoma in the hepatic dome. AJR Am J Roentgenol. 2004. 182:1224–1226.

27. Ohmoto K, Tsuzuki M, Yamamoto S. Percutaneous microwave coagulation therapy with intraperitoneal saline infusion for hepatocellular carcinoma in the hepatic dome. AJR Am J Roentgenol. 1999. 172:65–66.

28. Raman SS, Aziz D, Chang X, Sayre J, Lassman C, Lu D. Minimizing diaphragmatic injury during radiofrequency ablation: efficacy of intraabdominal carbon dioxide insufflation. AJR Am J Roentgenol. 2004. 183:197–200.

29. Raman SS, Lu DS, Vodopich DJ, Sayre J, Lassman C. Minimizing diaphragmatic injury during radio-frequency ablation: efficacy of subphrenic peritoneal saline injection in a porcine model. Radiology. 2002. 222:819–823.

30. Koda M, Ueki M, Maeda Y, Mimura K, Okamoto K, Matsunaga Y, et al. Percutaneous sonographically guided radiofrequency ablation with artificial pleural effusion for hepatocellular carcinoma located under the diaphragm. AJR Am J Roentgenol. 2004. 183:583–588.

31. Iochum S, Ludig T, Walter F, Sebbag H, Grosdidier G, Blum AG. Imaging of diaphragmatic injury: a diagnostic challenge? Radiographics. 2002. 22:S103–S116.